JPMorgan Claverhouse (LON:JCH) Share Price Passes Above 50-Day Moving Average - Should You Sell?

Key Points

• JPMorgan Claverhouse's stock price recently crossed above its 50-day moving average, trading at GBX 820 ($11.03) with a peak of GBX 822.80 ($11.06).
• The investment trust has a market cap of £453.93 million and reported a return on equity of 14.30% with a net margin of 92.61% in its latest quarterly earnings.
• Established in 1963, the trust focuses on UK large cap stocks, prioritizing high-quality companies that consistently generate and grow dividends.

JPMorgan Claverhouse (LON:JCH - Get Free Report)'s stock price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 803.03 ($10.80) and traded as high as GBX 822.80 ($11.06). JPMorgan Claverhouse shares last traded at GBX 820 ($11.03), with a volume of 83,127 shares trading hands.

JPMorgan Claverhouse Stock Performance

The stock has a market cap of £453.93 million, a PE ratio of 849.69 and a beta of 0.83. The company has a debt-to-equity ratio of 11.85, a current ratio of 0.71 and a quick ratio of 67.67. The business has a 50 day moving average price of GBX 803.03 and a two-hundred day moving average price of GBX 772.89.

JPMorgan Claverhouse (LON:JCH - Get Free Report) last released its quarterly earnings data on Thursday, August 14th. The investment trust reported GBX 18.96 earnings per share for the quarter. JPMorgan Claverhouse had a return on equity of 14.30% and a net margin of 92.61%.

About JPMorgan Claverhouse

Great British dividends The JPMorgan Claverhouse Investment Trust has been helping investors tap directly into the long-term growth potential of UK large cap stocks since 1963. The trust focuses on attractively valued, high quality stocks with the ability to generate consistent and growing dividends. Key points Expertise • Managed by an investment team with long-standing UK equity experience, backed by the extensive resources of J.P.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.